Investing
Top Analyst Upgrades (AKAM, BSX, CLX, CVA, ESRX, MCRS, PRXL, PFE, QSII, SGMS)
Published:
Last Updated:
These are some of the top analyst upgrades and positive calls we are seeing this Monday morning:
- Akamai (AKAM) Raised to Buy at Merriman Curhan Ford.
- Boston Scientific (BSX) Raised to Overweight at Thomas Weisel.
- Clorox (CLX) Raised to Buy at Goldman Sachs.
- Covanta (CVA) Raised to Overweight at JPMorgan.
- Express Scripts (ESRX) Raised to Buy at Goldman Sachs.
- Micros Systems (MCRS) Started as Outperform at Oppenheimer.
- PAREXEL (PRXL) Raised to Outperform at Wachovia.
- Pfizer (PFE) Raised to Outperform at Credit Suisse.
- Quality Systems (QSII) Raised to Buy at Piper Jaffray.
- Scientific Games (SGMS) Raised to Buy at Goldman Sachs.
Jon C. Ogg
February 2, 2009
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
